We use cookies for certain features and to improve your experience. See our Cookie Policy and Privacy Policy to learn more

Leafly

Shop legal, local weed.

Open
advertise on Leafly
ShopDeliveryDispensariesDealsStrainsBrandsProductsCBDDoctorsCannabis 101Social impact
  • Sign in
  • Create account
  • Strains
  • Shop
  • Shop
  • Delivery
  • Deals
  • Dispensaries
  • CBD Stores
  • Brands
  • Products
  • Learn
  • Cannabis 101
  • News
  • Leafly Learn
  • Science of cannabis
  • Doctors
  • Social impact
  • Lab partners
  • Download the Leafly App
  • Advertise on Leafly
    • Leafly.comUSA flag
    • Leafly.caCanadian flag
    • Leafly.deGerman flag
  • Help
  • News
  • Cannabis 101
  • Growing
  • Strains & products
  • CBD
  • Politics
  • Health
  • Lifestyle
  • Science & tech
  • Industry
  • Reports
  • Canada
  • Podcasts
  • Leafly Lists
Politics

Photos Prove Government-Grown Cannabis Is Basically Ditch Weed

Ben AdlinPublished on March 13, 2017 · Last updated July 28, 2020

Take a second to appreciate this picture.

If you’ve seen cannabis before, we’ll forgive you for not recognizing it here.

That bowl of what looks like stuff you might dig out of an old lawnmower is actually government-approved medical marijuana. Since the 1960s, the United States has required that  all cannabis used for research be sourced through the government.

And there it is, in all its glory.

No joke. The cannabis in that picture, the Washington Post reports, is the federally approved cannabis distributed to Sue Sisley, a researcher conducting a first-ever clinical trial of cannabis as a potential treatment for post-traumatic stress disorder (PTSD). To underscore the difference between government marijuana and the medical cannabis familiar to patients in most legal states, the Post published this side-by-side comparison:

(Washington Post)

(Washington Post)

“Inhaling that would be like eating an apple, including the seeds inside it and the branch it grew on,” professional cannabis critic Jake Browne told the Post. “People typically smoke the flower of the plant, but here you can clearly see stems and leaves in there as well.”

Or as Twitter user @lightningjeff put it, “That’s drug abuse right there on the right.”

“It's akin to investigating the effects of bourbon by giving people Bud Light.”

The PTSD researcher, Sisley, said she was disappointed when she first unwrapped the package. “It didn’t look like cannabis. It didn’t smell like cannabis,” she told PBS NewsHour, which described the substance’s as looking “like green talcum powder.”

Some of the samples Sisley received failed to conform to the chemical potency she’d requested for the study, she said. One strain, for example, was supposed to contain 13% THC. Sisley’s testing showed it was closer to 8%.

Other samples were contaminated with mold and yeast at levels that exceeded standards in adult-use states like Washington or Colorado.

The cannabis was, like all government-approved cannabis, grown on a 12-acre farm at the University of Mississippi, overseen by the National Institute on Drug Abuse. And while it may be a laughable product, it’s hardly a laughing matter.

“For a researcher, it’s difficult to assess the real-world impact of high-end pot if you only have access to the low-quality stuff,” write the Post’s Chris Ingraham and Tauhid Chappell. “It’s akin to investigating the effects of bourbon by giving people Bud Light.”

NIDA has said it plans to produce “some additional marijuana this year and harvest some high THC material that will likely be above 13 percent THC.”

Related Coverage

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • See all dispensaries
See all dispensaries
ArizonaMAPSmedical marijuanamississippinidaptsdresearch
Ben Adlin
Ben Adlin
Ben Adlin is a Seattle-based writer and editor who specializes in cannabis politics and law. He was a news editor for Leafly from 2015-2019. Follow him on Twitter: @badlin
View Ben Adlin's articles

The latest in Politics

  • How US import tariffs are impacting cannabis prices and products image
    How US import tariffs are impacting cannabis prices and products
    Leafly Staff
  • Ohioans must activate to defend cannabis freedoms from lawmakers image
    Ohioans must activate to defend cannabis freedoms from lawmakers
    David Downs
  • Montanans must activate to protect legalization in 2025 image
    Montanans must activate to protect legalization in 2025
    David Downs
  • Analysis: Don’t hold your breath for legalization under Trump 2.0 image
    Analysis: Don’t hold your breath for legalization under Trump 2.0
    David Downs
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

Something went wrong, please try again.

By providing us with your email address, you agree to Leafly’s Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App StoreDownload Leafly Marijuana Reviews on Google Play

Business Solutions
  • List your store
  • List your CBD store
  • List your brand
  • List your practice
  • Business log in

About Leafly
  • About us
  • Careers
  • Newsroom
  • Investor relations
  • Contact us
  • FAQs
  • Accessibility

Dispensaries in
  • Los Angeles
  • Seattle
  • Portland
  • San Francisco
  • Toronto
  • Detroit

Privacy & Terms
  • Terms of use
  • Commercial terms of use
  • Privacy policy
  • Do not sell my personal information

* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2025 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.